Cogent Biosciences, Inc. — Revenue by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/9378c2c6-ce37-4642-9557-3a330e1e674c/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2020 | $7.9M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-013325 |
| FY 2019 | $22.5M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-013188 |
| FY 2018 | $9.7M | 2018-01-01 – 2018-12-31 | evidence 0001193125-19-089299 |
| FY 2017 | $8.4M | 2017-01-01 – 2017-12-31 | evidence 0001193125-19-089299 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Cogent Biosciences, Inc. — all facts · Net Income · Operating Income